Titan Biotech Limited (BOM:524717)
400.95
+10.25 (2.62%)
At close: Jul 10, 2026
Titan Biotech Revenue
In the fiscal year ending March 31, 2026, Titan Biotech had annual revenue of 2.06B INR with 31.79% growth. Titan Biotech had revenue of 488.34M in the quarter ending March 31, 2026, with 38.85% growth.
Revenue
2.06B
Revenue Growth
+31.79%
P/S Ratio
8.02
Revenue / Employee
4.42M
Employees
467
Market Cap
16.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.06B | 497.40M | 31.79% |
| Mar 31, 2025 | 1.56B | -76.21M | -4.65% |
| Mar 31, 2024 | 1.64B | 200.73M | 13.94% |
| Mar 31, 2023 | 1.44B | 204.50M | 16.55% |
| Mar 31, 2022 | 1.24B | -186.92M | -13.14% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huhtamaki India | 24.74B |
| Dynacons Systems & Solutions | 14.24B |
| Sumeet Industries | 10.50B |
| Indosolar | 6.80B |
| Frontier Springs | 3.22B |
| Algoquant Fintech | 2.36B |
| CFF Fluid Control | 2.09B |
| NINtec Systems | 1.70B |